A Phase 1/2A Open-Label Study of Pralatrexate and Gemcitabine in Patients with Relapsed or Refractory Lympboprolifierative Malignancies 50th Annual Meeting of the American-Society-of-Hematology/ASH/ASCO Joint Symposium Horwitz, S. M., Vose, J. M., Advani, R., Sankhala, K., Padmanabhan, S., Hamlin, P. A., Chen, A., Wilroy, S., Zain, J. M., Wright, D., Weissbrot, H., Hohenstein, M., Cagnoni, P. J., Saunders, M. E., O'Connor, O. A. AMER SOC HEMATOLOGY. 2008: 557–57

View details for Web of Science ID 000262104701791